Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9037117 | Toxicology Letters | 2005 | 8 Pages |
Abstract
We investigated the relationship between lung- and skin-tumor promotion and oxidative stress caused by administration of dimethylarsinic acid (DMA(V)) in mice. The incidence of lung tumors induced by lung tumor initiator (4NQO) and DMA(V) were, as well as 8-oxo-2â²-deoxyguanosine (8-oxodG), suppressed by cotreatment with (â)epigallocatechin gallate (EGCG). When mice were topically treated with trivalent dimethylated arsenic (DMA(III)), a further reductive metabolite of DMA(V), not only an increase in skin tumors but also an elevation of 8-oxodG in epidermis were observed. These results suggest that tumor promotion due to DMA(V) administration is mediated by DMA(III) through the induction of oxidative stress.
Keywords
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Mutsumi Mizoi, Fumiyo Takabayashi, Masayuki Nakano, Yan An, Yuko Sagesaka, Koichi Kato, Shoji Okada, Kenzo Yamanaka,